MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


FTSE drops more than 1% after weak US data

StockMarketWire.com

FTSE drops more than 1% after weak US data

The FTSE 100 surrendered its gains from earlier in the week to trade down 1.4% at 6,617.15 by the close. This followed a weaker than expected update on the US jobs market.

This helped sustain gains for sterling against the dollar with the exchange rate very close to the $1.40 mark last seen in 2018. A strong pound impacts the relative value of the overseas earnings which dominate the FTSE.

By 4.30pm UK time the S&P 500 was down 0.8% to 3,900.12.

Medical technology company Smith & Nephew fell 5.9% to £14.75 as it reported a 42% fall in trading profits as consequences of the pandemic lead to a decreased revenue across the group as well as lower gross margins.

Hays fell 3% to 153.3p despite reporting a sharp fall in first-half profit. The recruitment company vowed to resume its dividend payments later this year in August, citing a stronger recovery in the second quarter.

Barclays fell 4.4% to 147.5p as profit was hit by £4.8 billion in bad loan provisions, though the company did resume dividend payments and announced a share buyback.

Price comparison website MoneySuperMarket.com was up 7.1% to 287p following a slump in profits in 2020 fuelled by the impact of Coronavirus and lockdowns in the UK. Profits at the company fell 27% to £69.3 million, from £94.9 million in 2019.

Drug maker Indivior swung to a loss in 2020 as revenue slipped amid competition from generic drugs to treat opioid dependence. For the year ended 31 December, the company reported a pre-tax loss $173 million, compared with a profit of $180 million year-on-year as revenue slipped to $647 million. Its share price sunk 6.5% to 139.3p.

Property investment trust Primary Health Properties has seen positive growth across its balance sheet, driven by a year of strong demand and improved management structure. Its share price remained stable at 148.60p on the back of the announcement.

Story provided by StockMarketWire.com